Evidence map›Paper›PMID 19319141›Full record

ArticleNature reviews. Immunology2009

Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?

Eric Vivier, Hergen Spits, Tom Cupedo

Abstract read
PubMed Publisher
In one paragraph

Article in Nature reviews. Immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 169 citations in OpenAlex.

  1. Association of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Trial
  2. Review
  3. Article
  4. Article
  5. Decidual CXCR4Clinical and translational medicine · 2021
    Article
  6. Role of Th22 Cells in Human Viral Diseases.Frontiers in medicine · 2021
    Review
  7. Innate Lymphoid Cells in Response to Intracellular Pathogens: ProtectionFrontiers in cellular and infection microbiology · 2021
    Review
  8. Article
  9. Article
  10. A cytokine network involving IL-36γ, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Activation of Natural Killer Cells by Probiotics.Forum on immunopathological diseases and therapeutics · 2016
    Article
  19. Airway epithelial NF-κB activation promotes the ability to overcome inhalational antigen tolerance.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015
    Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Eric VivierCentre d'Immunologie de Marseille-Luminy, Université de la Méditerranée, INSERM, U631, France.
Hergen Spits
Tom Cupedo
Centre d’Immunologie de Marseille-Luminy · FRErasmus MC · NLGenentech

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucosal tissues, lying at the interface with the external environment, are constantly challenged by microbial, physical and chemical assaults. To provide the necessary immune defence to such challenges, lymph nodes and Peyer's patches are formed in utero in response to inductive signals from lymphoid-tissue inducer (LTi) cells. As discussed in this Progress article, a series of recent reports has identified a population of interleukin-22-producing mucosal cells in the gut and tonsils that share features with both LTi cells (by expressing RORgammat) and natural killer cells (by expressing NKp46) and that might be involved in immunity and homeostasis in mucosal tissues.

Indexed as

AnimalsCell LineageHumansImmunity, InnateImmunity, MucosalInterleukin-22InterleukinsIntestinal MucosaKiller Cells, NaturalLymphocytesLymphoid Progenitor CellsMiceModels, BiologicalPalatine TonsilRegenerationInterleukin-22Interleukins

Identifiers

PMID19319141
OpenAlexW1978615362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.